Quote | Valeo Pharma (OTCMKTS:VPHIF)
Last: | $0.1348 |
---|---|
Change Percent: | 2.67% |
Open: | $0.1312 |
Close: | $0.1348 |
High: | $0.1348 |
Low: | $0.1312 |
Volume: | 2,670 |
Last Trade Date Time: | 03/25/2024 03:00:00 am |
News | Valeo Pharma (OTCMKTS:VPHIF)
VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. AL MOGHADDAM TO BOARD OF DIRECTORS Canada NewsWire MONTREAL , March 22, 2024 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical company, t...
VALEO PHARMA REPORTS FIRST QUARTER 2024 RESULTS Canada NewsWire Q1-24 revenues of $13.5 million , up 3% over Q1-23 Q1-24 adjusted EBITDA loss of $2.1 million compared to $2.2 million for Q1-23, down 6% Total Enerzair and Atectura prescriptions for...
Message Board Posts | Valeo Pharma (OTCMKTS:VPHIF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Valeo Pharma Company Name:
VPHIF Stock Symbol:
OTCMKTS Market:
VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. AL MOGHADDAM TO BOARD OF DIRECTORS Canada NewsWire MONTREAL , March 22, 2024 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical company, t...
VALEO PHARMA REPORTS FIRST QUARTER 2024 RESULTS Canada NewsWire Q1-24 revenues of $13.5 million , up 3% over Q1-23 Q1-24 adjusted EBITDA loss of $2.1 million compared to $2.2 million for Q1-23, down 6% Total Enerzair and Atectura prescriptions for...
VALEO PHARMA TO HOST FIRST QUARTER 2024 RESULTS CONFERENCE CALL / WEBCAST Canada NewsWire MONTREAL , March 7, 2024 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical company, annou...